Ionis Pharmaceuticals IONS Occupancy and Related Charges
Occupancy and Related Charges at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseExpense.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's occupancy and related charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's occupancy and related charges?
- Ionis Pharmaceuticals (IONS) reported occupancy and related charges of $6.5M in Q4 2025.
- How has Ionis Pharmaceuticals's occupancy and related charges changed year-over-year?
- Ionis Pharmaceuticals's occupancy and related charges increased by 12.1% year-over-year, from $5.8M to $6.5M.
- What is the long-term trend for Ionis Pharmaceuticals's occupancy and related charges?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's occupancy and related charges has grown at a 6.1% compound annual growth rate (CAGR), from $23.1M to $26M.
- What does occupancy and related charges mean?
- The accounting cost of leasing assets, recorded as an expense on the income statement.
- How do you interpret occupancy and related charges?
- Rising expenses relative to revenue may indicate declining efficiency in asset utilization.
- How does occupancy and related charges compare across companies?
- Standard accounting metric for all companies reporting under modern lease accounting standards.